Development of a dual-chambered microphysiological system to measure inflammatory pathologies using real-time and label-free bio-imaging AI techniques

• Forschungsstelle: INNOSUISSE
• Projektnummer: 122.132 IP-LS
• Projekttitel Englisch: Development of a dual-chambered microphysiological system to measure inflammatory pathologies using real-time and label-free bio-imaging AI techniques

Schlüsselwörter (Englisch)

Life sciences, Medtech

Abstract (Englisch)

MesenFlow has developed a platform to test inflammatory pathologies using human endothelium and leukocytes under flow. With HEPIA, they are implementing a next-generation dual chamber microphysiological system for neuroinflammation on their real time label-free imaging platform.